Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Capital Expenditures (2023)

Historic Capital Expenditures for Rallybio (RLYB) over the last 1 years, with Q3 2023 value amounting to $12000.0.

  • Rallybio's Capital Expenditures changed N/A to $12000.0 in Q3 2023 from the same period last year, while for Dec 2024 it was $12000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $12000.0 for FY2023, which is 7777.78% down from last year.
  • Rallybio's Capital Expenditures amounted to $12000.0 in Q3 2023.
  • Rallybio's 5-year Capital Expenditures high stood at $12000.0 for Q3 2023, and its period low was $12000.0 during Q3 2023.